Spyre Therapeutics, Inc. (SYRE)
109.03
+2.38
(+2.23%)
USD |
NASDAQ |
Aug 25, 09:31
Spyre Therapeutics Market Cap : 9.602B for Aug. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 9.392B |
| August 21, 2026 | 9.378B |
| August 20, 2026 | 9.492B |
| August 19, 2026 | 9.592B |
| August 18, 2026 | 9.495B |
| August 17, 2026 | 9.212B |
| August 14, 2026 | 9.126B |
| August 13, 2026 | 8.969B |
| August 12, 2026 | 9.167B |
| August 11, 2026 | 9.048B |
| August 10, 2026 | 9.276B |
| August 07, 2026 | 9.239B |
| August 06, 2026 | 9.108B |
| August 05, 2026 | 9.189B |
| August 04, 2026 | 9.241B |
| August 03, 2026 | 8.360B |
| July 31, 2026 | 7.752B |
| July 30, 2026 | 8.002B |
| July 29, 2026 | 7.716B |
| July 28, 2026 | 7.881B |
| July 27, 2026 | 7.887B |
| July 24, 2026 | 8.052B |
| July 23, 2026 | 7.883B |
| July 22, 2026 | 7.819B |
| July 21, 2026 | 8.097B |
| Date | Value |
|---|---|
| July 20, 2026 | 7.673B |
| July 17, 2026 | 7.902B |
| July 16, 2026 | 7.420B |
| July 15, 2026 | 8.047B |
| July 14, 2026 | 7.801B |
| July 13, 2026 | 7.390B |
| July 10, 2026 | 7.706B |
| July 09, 2026 | 7.785B |
| July 08, 2026 | 7.521B |
| July 07, 2026 | 7.429B |
| July 06, 2026 | 6.996B |
| July 02, 2026 | 6.830B |
| July 01, 2026 | 7.008B |
| June 30, 2026 | 6.999B |
| June 29, 2026 | 7.108B |
| June 26, 2026 | 6.929B |
| June 25, 2026 | 6.991B |
| June 24, 2026 | 6.799B |
| June 23, 2026 | 7.651B |
| June 22, 2026 | 7.909B |
| June 18, 2026 | 6.965B |
| June 17, 2026 | 6.898B |
| June 16, 2026 | 6.576B |
| June 15, 2026 | 6.589B |
| June 12, 2026 | 6.369B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AbbVie, Inc. | 466.66B |
| vTv Therapeutics, Inc. | 130.02M |
| BridgeBio Pharma, Inc. | 15.95B |
| Praxis Precision Medicines, Inc. | 10.33B |
| ACADIA Pharmaceuticals, Inc. | 5.141B |
Market Cap Related Metrics
| Price to Book Value | 10.06 |
| Price | 109.03 |
| Earnings Yield | -2.00% |